{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:21:51Z","timestamp":1649125311491},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Urology and Nephrology"],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1007\/bf02551351","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T11:34:45Z","timestamp":1167996885000},"page":"251-258","source":"Crossref","is-referenced-by-count":0,"title":["1.25 (OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of haemodialysis patients"],"prefix":"10.1007","volume":"29","author":[{"given":"M.","family":"Boran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Doruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"G\u00f6nen\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"\u00c7etin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02551351_CR1","first-page":"679","volume-title":"Renal Osteodystrophy and Maintenance Dialysis in Replacement of Renal Function by Dialysis","author":"J. W. Coburn","year":"1990","unstructured":"Coburn, J. W., Llach, F.: In: Drucker, W., Parsons, F. M., Maher, C. F., (eds): Renal Osteodystrophy and Maintenance Dialysis in Replacement of Renal Function by Dialysis. Martinus Nijhoff, Dordrecht 1990, p. 679."},{"key":"BF02551351_CR2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(78)91137-6","volume":"1","author":"K. Y. Ahmet","year":"1978","unstructured":"Ahmet, K. Y., Varghesse, Z., Wills, M. R.: Long-term effect of small doses of 1.25 (OH)2 cholecalciferol in renal osteodystrophyLancet, 1, 629 (1978).","journal-title":"Lancet"},{"key":"BF02551351_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00566316","volume":"13","author":"S. Madsen","year":"1970","unstructured":"Madsen, S., Olgoard, K.: Long-term trail of 1 alfa hydroxycholecalciferol in adults with chronic failure,Eur. J. Clin. Pharmacol., 13, 401 (1970).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF02551351_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000403276","volume":"18","author":"D. J. Cherrard","year":"1980","unstructured":"Cherrard, D. J., Coburn, J. W., Brickman, A. S.: Skeletal response to treatment with 1.25 (OH)2 cholecalciferol in renal failure.Contrib. Nephrol., 18, 92 (1980).","journal-title":"Contrib. Nephrol."},{"key":"BF02551351_CR5","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/endo-117-5-2114","volume":"117","author":"L. K. Cantley","year":"1975","unstructured":"Cantley, L. K., Russel, K. J., Lettieri, D.: 1.25 (OH)2 cholecalciferol suppresses parathyroid hormone secretion from parathyroid cells in tissue culture.Endocrinology, 117, 2114 (1975).","journal-title":"Endocrinology"},{"key":"BF02551351_CR6","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/endo-119-6-2864","volume":"119","author":"J. Russel","year":"1986","unstructured":"Russel, J., Lettieri, D., Sherwood, L. H.: Suppression by 1.25 (OH)2 cholecalciferol of transcription of the parathyroid hormone gene.Endocrinology, 119, 2864 (1986).","journal-title":"Endocrinology"},{"key":"BF02551351_CR7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","volume":"78","author":"J. Silver","year":"1986","unstructured":"Silver, J., Naveb-Many, T., Mayer, H.: Regulation by Vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.J. Clin. Invest., 78, 1296 (1986).","journal-title":"J. Clin. Invest."},{"key":"BF02551351_CR8","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","volume":"74","author":"E. Slatopolsky","year":"1984","unstructured":"Slatopolsky, E., Weerts, C., Thielan, J., Herst, R., Harter, H., Martin, K. J.: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1.25 (OH)2 cholecalciferol in uremic patients.J. Clin. Invest., 74, 2136 (1984).","journal-title":"J. Clin. Invest."},{"key":"BF02551351_CR9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ki.1989.305","volume":"36","author":"R. Dunlay","year":"1989","unstructured":"Dunlay, R., Rodriguez, M., Felsenfelt, A. J., Llach, F.: Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.Kidney Int., 36, 1093 (1989).","journal-title":"Kidney Int."},{"key":"BF02551351_CR10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","volume":"83","author":"J. A. Delmez","year":"1989","unstructured":"Delmez, J. A., Tindra, C., Grooms, P., Dusso, A., Windus, D. W., Slatopolsky, E.: Parathyroid hormone suppression by intravenous 1.25 (OH)2 cholecalciferol. A role for increased sensitivity to calcium.J. Clin. Invest., 83, 1349 (1989).","journal-title":"J. Clin. Invest."},{"key":"BF02551351_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM199008093230617","volume":"323","author":"M. Fukagawa","year":"1990","unstructured":"Fukagawa, M., Okazaki, R., Takanu, K., Kaname, S. Y., Kurokawa, K.: Regression of parathyroid hyperplasia by calcitriol pulse therapy in patients on long-terms dialysis.N. Engl. J. Med., 323, 421 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BF02551351_CR12","first-page":"829","volume":"7","author":"J. I. C. Kwan","year":"1992","unstructured":"Kwan, J. I. C., Almond, M. K., Beer, J. C., Noonan, K., Evans, S. J. W., Cunningham, J.: Pulse oral calcitriol in uraemic patients: Rapid modification of parathyroid response to calcium.Nephrol. Dial. Transpl., 7, 829 (1992)","journal-title":"Nephrol. Dial. Transpl."},{"key":"BF02551351_CR13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","volume":"321","author":"D. L. Andress","year":"1989","unstructured":"Andress, D. L., Norris, K. C., Coburn, J. W., Slatopolsky, E. A., Sherrard, D. J.: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.N. Engl. J. Med., 321, 274 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BF02551351_CR14","first-page":"216","volume":"40","author":"E. R. Fisher","year":"1993","unstructured":"Fisher, E. R., Harris, D. C. H.: Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.Clin. Nephrol., 40, 216 (1993).","journal-title":"Clin. Nephrol."},{"key":"BF02551351_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000186210","volume":"57","author":"Y. Tsukomato","year":"1991","unstructured":"Tsukomato, Y., Nomura, M., Takahashi, Y., Takagi, A., Nagaoka, T., Togashi, K., Kikawada, R., Marumo, F.: The oral 1.25 (OH)2 cholecalciferol pulse therapy in hemodialysis patients with severe secondary hyperparathyroidismNephron, 57, 23 (1991).","journal-title":"Nephron"},{"key":"BF02551351_CR16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000186438","volume":"58","author":"H. Muramoto","year":"1991","unstructured":"Muramoto, H., Haruki, K., Yoshimura, A., Mimo, N., Oda, K., Tofuku, Y.: Treatment of refractory hyperparathyroidism in patients on hemodialysis by intermittent oral administration of 1.25 (OH)2 cholecalciferol.Nephron, 58, 288 (1991).","journal-title":"Nephron"},{"issue":"Suppl 41","key":"BF02551351_CR17","first-page":"125","volume":"43","author":"F. Malberti","year":"1993","unstructured":"Malberti, F., Surian, M., Cosci, P.: Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.Kidney Int., 43(Suppl 41), 125 (1993).","journal-title":"Kidney Int."},{"key":"BF02551351_CR18","first-page":"753","volume":"7","author":"M. Alm de Francisco","year":"1992","unstructured":"Alm de Francisco, M., Prieto, J. A., Amado, S. C., Ruiz, S. C., De Castro, G., Alcalde, P., Morales, M., Arias, H. U.: Dialysis membranes and PTH changes during hemodialysis (Abstract).Nephrol. Dial. Transpl., 7, 753 (1992)","journal-title":"Nephrol. Dial. Transpl."},{"key":"BF02551351_CR19","first-page":"758","volume":"8","author":"E. Fernandes","year":"1992","unstructured":"Fernandes, E., Bertlu, M. A., Cao, G., Rivas, M. C., Montoliu, J.: Hyperphosphatemia stimulates PTH secretion by a direct, calcium independent mechanism (Abstract).Nephrol. Dial. Transpl., 8, 758 (1992).","journal-title":"Nephrol. Dial. Transpl."},{"issue":"Suppl. 41","key":"BF02551351_CR20","first-page":"121","volume":"43","author":"P. H. Moriniere","year":"1993","unstructured":"Moriniere, P. H., Esper, N. E. L., Viron, B., Judith, D., Bourgeon, B., Farquet, C. H., Gheerbrant, J. D., Chapuy, M. C., Van Orshoven, A., Pamphile R., Fournier, A.: Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alfa (OH) cholecalciferol, oral calcium carbonate and low dialysate calcium.Kidney Int., 43 (Suppl. 41), 121 (1993).","journal-title":"Kidney Int."},{"key":"BF02551351_CR21","first-page":"760","volume":"7","author":"H. H. Klehr","year":"1992","unstructured":"Klehr, H. H., Hristea, D., Klein, B., Paar, D.: Treatment of severe secondary hyperparathyroidism with oral calcitriol pulse therapy depending on body weight (Abstract).Nephrol. Dial. Transpl., 7, 760 (1992).","journal-title":"Nephrol. Dial. Transpl."},{"key":"BF02551351_CR22","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/ndt\/5.10.874","volume":"5","author":"W. M. Merve Van der","year":"1990","unstructured":"Van der Merve, W. M., Rodger, R. S. C., Grant, A. C., Loque, F. C., Cowan, R. A., Beastall, G. H., Junor, B. J., Briggs, J. D.: Low calcium dialysate and high dose oral calcitriol in the treatment of secondary hyperparathyroidism in hemodialysis patients.Nephrol. Dial. Transpl., 5, 874 (1990).","journal-title":"Nephrol. Dial. Transpl."},{"key":"BF02551351_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.1980.154","volume":"18","author":"S. G. Massry","year":"1980","unstructured":"Massry, S. G., Goldstein, D. A., Malluche, H. H.: Current status of the use of 1.25 (OH)2 cholecalciferol in the management of renal osteodystrophy.Kidney Int., 18, 409 (1980).","journal-title":"Kidney Int."},{"key":"BF02551351_CR24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.52.6.464","volume":"52","author":"A. M. Pierides","year":"1972","unstructured":"Pierides, A. M., Ellis, H. A., Dellagrammatikas, H., Scott, J. E., Norman, A. W.: 1.25 (OH)2 cholecalciferol in renal osteodystrophy.Arch. Dis. Child., 52, 464 (1972).","journal-title":"Arch. Dis. Child."},{"key":"BF02551351_CR25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0140-6736(91)91429-X","volume":"337","author":"G. Klaus","year":"1991","unstructured":"Klaus, G., Mebls, O., Flinderer, J., Ritz, E.: Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?Lancet, 337, 800 (1991).","journal-title":"Lancet"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02551351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02551351\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02551351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T21:50:03Z","timestamp":1558302603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02551351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["BF02551351"],"URL":"https:\/\/doi.org\/10.1007\/bf02551351","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}